Skip to main content

Table 2 Prevalence of anemia among patients with T2DM in different subgroup

From: Prevalence of anemia and its associated factors among patients with type 2 diabetes mellitus in a referral diabetic clinic in the north of Iran

 

Case/Total

Crude prevalence % (95% CI)

P-value

Obesity

  

0.032

Non-obese

53/292

18.2 (13.9–23.1)

 

Obese

36/132

27.3(19.9–35.7)

 

Gender

  

0.708

Women

67/306

21.9(17.4–27.0)

 

Men

22/109

20.2(13.1–29.0)

 

Diabetes Duration

  

<0.001

< 5 years

18/162

11.1(6.7–17.0)

 

> 5 years

71/253

28.1(22.6–34.0)

 

Hb A1c

  

0.001

≥ 7

11/106

10.4(5.3–17.8)

 

> 7

78/309

25.2(20.5–30.5)

 

Albuminuria

  

<0.001

No

64/375

17.1(13.4–21.3)

 

Yes

25/40

62.5(45.8-77.3)

 

GLD

  

<0.001

Oral

52/300

17.3(13.2–22.1)

 

Insulin

24/77

31.2(21.1–42.7)

 

Oral + Insulin

13/38

34.2(19.6–51.4)

 

CKD

  

<0.001

No

62/362

17.1 (13.4–21.4)

 

Yes

27/53

50.9(36.8-64.9)

 

Triglyceride

  

0.023

≤ 150

39/226

17.3 (12.6–22.8)

 

> 150

50/189

26.5 (20.3–33.4)

 

TC

  

0.066

≤ 200

67/340

19.7(15.6–24.3)

 

> 200

22/75

29.3 (19.4–41.0)

 

LDL-C

  

0.688

≤ 100

65/296

22.0(17.4–27.1)

 

> 100

24/119

20.2 (13.4–28.5)

 

HDL-C

  

0.240

≤ 40

63/272

23.2 (18.3–28.6)

 

> 40

26/143

18.2(12.2-25.5)

 
  1. Each group of categorical variables compared by Chi-square test; GLD: glucose lowering drug; CKD: chronic kidney disease; TC: total cholesterol; LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol; T2DM: Type 2 diabetes mellitus
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us